Abattis Bioceuticals announced it completed the previously announced acquisition of Green Tree Therapeutics.
As a result of the Acquisition, Green Tree is now a wholly-owned subsidiary of Abattis and Green Tree’s products will become available through Abattis’s wholly-owned subsidiary Vergence Naturals Ltd.
“The closing of our acquisition of Green Tree represents a significant milestone for Abattis,” stated Rob Abenante, President and CEO of Abattis. “We have now expanded our retail presence and established a solid entry point into the vaporizers market. In connection with the Acquisition, we look to merge our complementary businesses to expand our product lines and customer base.”
Click here to read the full press release.